afr article re cuv, page-10

At this point, I would wager there will be no Phase III US EPP trial for another year. From what my contact at the APF was saying, it did not look good in late March, so I would be shocked if there was one starting now.

If the FDA has made a final decision on not allowing a Phase III US trial in 2010, then this is IMO very signficant news and the company needs to address this. Past market reports have projected the company moving forward this year with some EPP trial in the US. So if they can't do this, the market deserves to be told so with an explanation.

I haven't asked the APF contact the past couple weeks because I've basically given up on it.

Also, shareholders deserve an update on cuv9900. It did not happen in Q1.

I am extremely disappointed with several things here. I invested b/c of the technology but I have sold many shares b/c of the innumerable delays from this team and I can't see this getting back to where it was in April 2007 for a long time.

Still hold a lot of shares, but sure wish I would have dumped all in April 2007.